ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 134 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 187,143 | $765,415 | 25.27% |
Decheng Capital LLC | 3,070,442 | $12,558,107 | 3.85% |
MPM BioImpact LLC | 1,450,000 | $5,930,500 | 0.92% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 961,486 | $3,932,478 | 0.80% |
Eventide Asset Management | 8,547,896 | $34,960,895 | 0.60% |
5AM Venture Management, LLC | 490,000 | $2,004,100 | 0.45% |
Matrix Capital Management Company, LP | 13,959,973 | $57,096,290 | 0.44% |
Values First Advisors, Inc. | 74,925 | $306,443 | 0.18% |
Boxer Capital, LLC | 450,000 | $1,840,500 | 0.10% |
GSA CAPITAL PARTNERS LLP | 255,201 | $1,044 | 0.07% |